Literature DB >> 34815975

Human-animal interspecies chimerism via blastocyst complementation: advances, challenges and perspectives: a narrative review.

Yuhang Li1,2,3, Ke Huang1,3.   

Abstract

OBJECTIVE: Interspecific human-animal chimerism via blastocyst complementation provides a promising strategy to generate function human cells, tissues or organs from human pluripotent stem cells (hPSCs), although it is still quite challenging. In this review, we will mainly focus on the recent advances, such as the options of donor hPSCs and the understanding of interspecific chimera barriers, challenges, and perspectives on the efficient generation of human-animal interspecies chimeras.
BACKGROUND: hPSCs, including the human embryonic stem cells (hESCs) and the human induced pluripotent stem cells (hiPSCs) hold great promise for regenerative medicine to treat various degenerative diseases. However, although hPSCs can differentiate to all lineage cells in dish, the functionality of these cells is limited, hinting that the in vitro differentiation system failed to fully recapture the in vivo development. A promising alternative strategy is in vivo generation of functional human cells in animals through interspecies chimerism, based on the principle that mammalian development is highly conserved across species. This strategy was inspired by the successful generation of functional rat pancreas in mice through blastocyst injection of rat pluripotent stem cells (PSCs). Over the past ten years, since this milestone work was reported, advances have been made in the human-animal interspecies chimerism. However, it is still challenging to efficiently generate human cells, tissues, or organs in the interspecies chimeras. This phenomenon suggests that there are still obstacles to illustrate and overcome implicated in human-animal interspecies chimeras.
METHODS: Narrative overview of the literatures reported the recent advances, challenges and perspectives regarding the interspecies chimerism via blastocyst complementation.
CONCLUSIONS: Human-animal interspecies chimerism via blastocyst complementation is a valuable method to generate functional human cells, tissues or organs, while there are at least three barriers need to be overcome. Firstly, conventional hPSCs should be converted to possess the chimera competency; secondly, efficient human-animal chimerism are required to robustly generate human derivatives in chimera; thirdly, the discrepancy regarding the developmental regulation network between human and host animals must be eliminated to generate certain human cells, tissues or organs in the interspecies chimeras. 2021 Stem Cell Investigation. All rights reserved.

Entities:  

Keywords:  Human pluripotent stem cell (hPSC); barrier; interspecies chimeras; regenerative medicine

Year:  2021        PMID: 34815975      PMCID: PMC8578738          DOI: 10.21037/sci-2020-074

Source DB:  PubMed          Journal:  Stem Cell Investig        ISSN: 2306-9759


  46 in total

1.  Organ size is limited by the number of embryonic progenitor cells in the pancreas but not the liver.

Authors:  Ben Z Stanger; Akemi J Tanaka; Douglas A Melton
Journal:  Nature       Date:  2007-01-28       Impact factor: 49.962

Review 2.  Hurdles to Generating Human Islets in Animals via Blastocyst Complementation.

Authors:  Tomoyuki Yamaguchi
Journal:  Curr Diab Rep       Date:  2019-06-24       Impact factor: 4.810

3.  Generation of rat pancreas in mouse by interspecific blastocyst injection of pluripotent stem cells.

Authors:  Toshihiro Kobayashi; Tomoyuki Yamaguchi; Sanae Hamanaka; Megumi Kato-Itoh; Yuji Yamazaki; Makoto Ibata; Hideyuki Sato; Youn-Su Lee; Jo-Ichi Usui; A S Knisely; Masumi Hirabayashi; Hiromitsu Nakauchi
Journal:  Cell       Date:  2010-09-03       Impact factor: 41.582

4.  Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells.

Authors:  Kevin A D'Amour; Anne G Bang; Susan Eliazer; Olivia G Kelly; Alan D Agulnick; Nora G Smart; Mark A Moorman; Evert Kroon; Melissa K Carpenter; Emmanuel E Baetge
Journal:  Nat Biotechnol       Date:  2006-10-19       Impact factor: 54.908

5.  Human thrombopoietin knockin mice efficiently support human hematopoiesis in vivo.

Authors:  Anthony Rongvaux; Tim Willinger; Hitoshi Takizawa; Chozhavendan Rathinam; Wojtek Auerbach; Andrew J Murphy; David M Valenzuela; George D Yancopoulos; Elizabeth E Eynon; Sean Stevens; Markus G Manz; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-24       Impact factor: 11.205

6.  Human somatic cell nuclear transfer using adult cells.

Authors:  Young Gie Chung; Jin Hee Eum; Jeoung Eun Lee; Sung Han Shim; Vicken Sepilian; Seung Wook Hong; Yumie Lee; Nathan R Treff; Young Ho Choi; Erin A Kimbrel; Ralph E Dittman; Robert Lanza; Dong Ryul Lee
Journal:  Cell Stem Cell       Date:  2014-04-17       Impact factor: 24.633

7.  Human TLR10 is an anti-inflammatory pattern-recognition receptor.

Authors:  Marije Oosting; Shih-Chin Cheng; Judith M Bolscher; Rachel Vestering-Stenger; Theo S Plantinga; Ineke C Verschueren; Peer Arts; Anja Garritsen; Hans van Eenennaam; Patrick Sturm; Bart-Jan Kullberg; Alexander Hoischen; Gosse J Adema; Jos W M van der Meer; Mihai G Netea; Leo A B Joosten
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-06       Impact factor: 11.205

8.  An early haematopoietic defect in mice lacking the transcription factor GATA-2.

Authors:  F Y Tsai; G Keller; F C Kuo; M Weiss; J Chen; M Rosenblatt; F W Alt; S H Orkin
Journal:  Nature       Date:  1994-09-15       Impact factor: 49.962

9.  Clinical-grade stem cell-derived retinal pigment epithelium patch rescues retinal degeneration in rodents and pigs.

Authors:  Ruchi Sharma; Vladimir Khristov; Aaron Rising; Balendu Shekhar Jha; Roba Dejene; Nathan Hotaling; Yichao Li; Jonathan Stoddard; Casey Stankewicz; Qin Wan; Connie Zhang; Mercedes Maria Campos; Kiyoharu J Miyagishima; David McGaughey; Rafael Villasmil; Mary Mattapallil; Boris Stanzel; Haohua Qian; Wai Wong; Lucas Chase; Steve Charles; Trevor McGill; Sheldon Miller; Arvydas Maminishkis; Juan Amaral; Kapil Bharti
Journal:  Sci Transl Med       Date:  2019-01-16       Impact factor: 17.956

10.  Transient inhibition of mTOR in human pluripotent stem cells enables robust formation of mouse-human chimeric embryos.

Authors:  Zhixing Hu; Hanqin Li; Houbo Jiang; Yong Ren; Xinyang Yu; Jingxin Qiu; Aimee B Stablewski; Boyang Zhang; Michael J Buck; Jian Feng
Journal:  Sci Adv       Date:  2020-05-13       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.